Immutep (IMMP) Cash & Equivalents (2017 - 2025)

Immutep (IMMP) has disclosed Cash & Equivalents for 8 consecutive years, with $43.2 million as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, Cash & Equivalents fell 59.51% year-over-year to $43.2 million, compared with a TTM value of $43.2 million through Jun 2025, down 59.51%, and an annual FY2025 reading of $43.7 million, down 58.83% over the prior year.
  • Cash & Equivalents was $43.2 million for Q2 2025 at Immutep, down from $106.6 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $106.6 million in Q2 2024 and bottomed at $43.2 million in Q2 2025.
  • Average Cash & Equivalents over 5 years is $67.2 million, with a median of $57.3 million recorded in 2022.
  • The sharpest move saw Cash & Equivalents surged 170.46% in 2021, then crashed 59.51% in 2025.
  • Year by year, Cash & Equivalents stood at $46.7 million in 2021, then rose by 22.8% to $57.3 million in 2022, then surged by 43.96% to $82.5 million in 2023, then rose by 29.26% to $106.6 million in 2024, then plummeted by 59.51% to $43.2 million in 2025.
  • Business Quant data shows Cash & Equivalents for IMMP at $43.2 million in Q2 2025, $106.6 million in Q2 2024, and $82.5 million in Q2 2023.